PITUM

This brand name is authorized in Nigeria.

Active ingredients

The drug PITUM contains one active pharmaceutical ingredient (API):

1	Ceftazidime UNII 9M416Z9QNR - CEFTAZIDIME
	Ceftazidime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Ceftazidime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8939	Injection	Pitum Injection 1000 mg+++ INJ 1000 mg 10 mL (in transparant glass vial)	Powder for injection 10/30/2024 17:22:10 PITUM INJECTION 1000MG CEFTAZIDIME B4-8939 POWDER FOR INJECTION INTRAMUSCULAR/INTRAVENOUS CEFTAZIDIME BP 1G & STERILISED WATER FOR INJECTIONS BP 10ML 1000MG 1 X 1000MG POM PINNACLE HEALTH PHARMACEUTICAL & STORES LTD. 16/18 NURU ONIWO STREET, AGUDA, SURULERE, LAGOS, NIGERIA. FINECURE PHARMACEUTICALS LTD. RUDRAPUR, DISTT. UDHAM SINGH NAGAR, UTTARAKHAND, INDIA INDIA 03/07/2020 03/07/2025 Yes NIL	03/07/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD02	Ceftazidime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8939